Pathological Fracture In Odontoid Process In Multiple Myeloma.
Demirci U et al. Turk J Haematol. 2016 Sep 23. doi: 10.4274/tjh.2016.0020. [Epub ahead of print].

Pinpointing a Factor in Myeloma Bone Disease.
[No authors listed]. Cancer Discov. 2016 Sep 22. [Epub ahead of print].

Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.
Wanchoo R et al. Clin J Am Soc Nephrol. 2016 Sep 21. pii: CJN.06100616. [Epub ahead of print].

Polycythaemia: an unusual presentation of multiple myeloma.
Hutchison EJ et al. BMJ Case Rep. 2016 Sep 20;2016. pii: bcr2016216686. doi: 10.1136/bcr-2016-216686.

Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy.
Katagiri S et al. Haemophilia. 2016 Sep 19. doi: 10.1111/hae.13077. [Epub ahead of print].

Poster 432 Cauda Equina Compression Secondary to a Rare Form of Metastatic Extra-Osseous Myeloma. A Case Report.
Kainth HS et al. PM R. 2016 Sep;8(9S):S302. doi: 10.1016/j.pmrj.2016.07.357. Epub 2016 Sep 24.

Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A Review.
Li W et al. JAMA Oncol. 2016 Sep 15. doi: 10.1001/jamaoncol.2016.3350. [Epub ahead of print].

C3 glomerulonephritis in multiple myeloma: A case report and literature review.
Yin G et al. Medicine (Baltimore). 2016 Sep;95(37):e4843. doi: 10.1097/MD.0000000000004843.

Extreme Amyloid Depositions in the Calvarium and Dura Associated With Plasma Cell Myeloma.
Wang AR et al. Int J Surg Pathol. 2016 Sep 14. pii: 1066896916668991. [Epub ahead of print].

Endocarditis due to Gemella haemolysans in a newly diagnosed multiple myeloma patient.
Liu D et al. J Community Hosp Intern Med Perspect. 2016 Sep 7;6(4):32357. doi: 10.3402/jchimp.v6.32357. eCollection 2016.

What Do Myeloma, Breast Cancer, and Prostate Cancer Have in Common?
Isaacs WB et al. Eur Urol. 2016 Sep 3. pii: S0302-2838(16)30531-0. doi: 10.1016/j.eururo.2016.08.058. [Epub ahead of print].

Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases formultiple myeloma: A systematic review and meta-analysis.
Teh BW et al. Eur J Cancer. 2016 Sep 1;67:21-37. doi: 10.1016/j.ejca.2016.07.025. [Epub ahead of print].

The relationship between spinopelvic measurements and patient-reported outcome scores in patients withmultiple myeloma of the spine.
Yu HM et al. Bone Joint J. 2016 Sep;98-B(9):1234-9. doi: 10.1302/0301-620X.98B9.37786.

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
Whited L et al. Pharmacotherapy. 2016 Sep;36(9):1003-10. doi: 10.1002/phar.1807. Epub 2016 Sep 6.